Financhill
Buy
75

MPC Quote, Financials, Valuation and Earnings

Last price:
$203.25
Seasonality move :
0.37%
Day range:
$195.75 - $204.32
52-week range:
$115.10 - $210.32
Dividend yield:
1.84%
P/E ratio:
15.24x
P/S ratio:
0.47x
P/B ratio:
2.49x
Volume:
1.6M
Avg. volume:
2.4M
1-year change:
31.91%
Market cap:
$60B
Revenue:
$132.5B
EPS (TTM):
$13.34
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $119.8B $177.4B $148.5B $138.5B $132.5B
Revenue Growth (YoY) 73.2% 48.12% -16.32% -6.7% -4.31%
 
Cost of Revenues $112.9B $154.9B $131.9B $129.5B $122.7B
Gross Profit $6.8B $22.6B $16.6B $9B $9.8B
Gross Profit Margin 5.71% 12.71% 11.18% 6.52% 7.43%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.5B $2.8B $3B $3.2B $3.3B
Other Inc / (Exp) $814M $2.5B $1.9B $1.5B --
Operating Expenses $2.5B $2.8B $3B $3.2B $3.3B
Operating Income $4.3B $19.8B $13.6B $5.8B $6.5B
 
Net Interest Expenses $1.3B $1.2B $1.3B $1.3B $1.3B
EBT. Incl. Unusual Items $2.8B $20.5B $14B $6B $7B
Earnings of Discontinued Ops. $8.4B $72M -- -- --
Income Tax Expense $264M $4.5B $2.8B $890M $1.1B
Net Income to Company $11B $16.1B $11.2B $5.1B --
 
Minority Interest in Earnings $1.3B $1.5B $1.5B $1.6B $1.8B
Net Income to Common Excl Extra Items $2.6B $16B $11.2B $5.1B $5.9B
 
Basic EPS (Cont. Ops) $2.71 $28.34 $23.76 $10.12 $13.27
Diluted EPS (Cont. Ops) $2.69 $28.12 $23.65 $10.09 $13.22
Weighted Average Basic Share $634M $512M $407M $340M $305M
Weighted Average Diluted Share $638M $516M $409M $341M $306M
 
EBITDA $7.6B $23B $16.9B $9.2B $9.7B
EBIT $4.3B $19.8B $13.6B $5.8B $6.5B
 
Revenue (Reported) $119.8B $177.4B $148.5B $138.5B $132.5B
Operating Income (Reported) $4.3B $19.8B $13.6B $5.8B $6.5B
Operating Income (Adjusted) $4.3B $19.8B $13.6B $5.8B $6.5B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $35.3B $39.7B $36.3B $33.1B $32.8B
Revenue Growth (YoY) 97.02% 12.55% -8.48% -8.99% -0.67%
 
Cost of Revenues $33B $34.4B $33.3B $31.4B $29.7B
Gross Profit $2.3B $5.3B $3B $1.7B $3.2B
Gross Profit Margin 6.4% 13.45% 8.26% 5.13% 9.61%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $656M $763M $820M $804M $836M
Other Inc / (Exp) $139M $280M $568M $329M --
Operating Expenses $656M $763M $820M $804M $836M
Operating Income $1.6B $4.6B $2.2B $891M $2.3B
 
Net Interest Expenses $305M $324M $323M $322M $343M
EBT. Incl. Unusual Items $1.3B $4.6B $2.3B $896M $2.4B
Earnings of Discontinued Ops. -- $72M -- -- --
Income Tax Expense $243M $984M $407M $111M $372M
Net Income to Company $1.1B $3.6B $1.9B $785M --
 
Minority Interest in Earnings $331M $320M $426M $414M $444M
Net Income to Common Excl Extra Items $1.1B $3.6B $1.9B $784M $2B
 
Basic EPS (Cont. Ops) $1.28 $7.14 $3.85 $1.16 $5.13
Diluted EPS (Cont. Ops) $1.27 $7.09 $3.84 $1.16 $5.12
Weighted Average Basic Share $605M $465M $376M $320M $299M
Weighted Average Diluted Share $609M $468M $377M $321M $300M
 
EBITDA $2.4B $5.4B $3B $1.7B $3.1B
EBIT $1.6B $4.6B $2.2B $891M $2.3B
 
Revenue (Reported) $35.3B $39.7B $36.3B $33.1B $32.8B
Operating Income (Reported) $1.6B $4.6B $2.2B $891M $2.3B
Operating Income (Adjusted) $1.6B $4.6B $2.2B $891M $2.3B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $119.8B $177.4B $148.5B $138.5B $132.5B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $112.9B $154.3B $131.9B $129.6B $122.7B
Gross Profit $6.8B $23.1B $16.6B $8.9B $9.9B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.5B $2.8B $3B $3.2B $3.3B
Other Inc / (Exp) $814M $2.5B $1.9B $1.6B --
Operating Expenses $2.5B $2.8B $3B $3.2B $3.3B
Operating Income $4.3B $20.3B $13.6B $5.7B $6.5B
 
Net Interest Expenses $1.3B $1.2B $1.3B $1.3B $1.4B
EBT. Incl. Unusual Items $2.8B $20.5B $14B $6B $7B
Earnings of Discontinued Ops. $8.4B $72M -- -- --
Income Tax Expense $264M $4.5B $2.8B $890M $1.1B
Net Income to Company $11B $16.1B $11.2B $5.1B --
 
Minority Interest in Earnings $1.3B $1.5B $1.5B $1.6B $1.8B
Net Income to Common Excl Extra Items $2.6B $16B $11.2B $5.1B $5.9B
 
Basic EPS (Cont. Ops) $2.76 $28.79 $23.65 $9.97 $13.37
Diluted EPS (Cont. Ops) $2.74 $28.60 $23.53 $9.94 $13.34
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $7.6B $23.5B $16.9B $9B $9.8B
EBIT $4.3B $20.3B $13.6B $5.7B $6.5B
 
Revenue (Reported) $119.8B $177.4B $148.5B $138.5B $132.5B
Operating Income (Reported) $4.3B $20.3B $13.6B $5.7B $6.5B
Operating Income (Adjusted) $4.3B $20.3B $13.6B $5.7B $6.5B
Period Ending 2022-12-31 2023-12-31 2024-12-31 2025-12-31 2026-12-31
Revenue $177.4B $148.5B $138.5B $132.5B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $154.3B $131.9B $129.6B $122.7B --
Gross Profit $23.1B $16.6B $8.9B $9.9B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.8B $3B $3.2B $3.3B --
Other Inc / (Exp) $2.5B $1.9B $1.6B $630M --
Operating Expenses $2.8B $3B $3.2B $3.3B --
Operating Income $20.3B $13.6B $5.7B $6.5B --
 
Net Interest Expenses $1.2B $1.3B $1.3B $1.4B --
EBT. Incl. Unusual Items $20.5B $14B $6B $7B --
Earnings of Discontinued Ops. $72M -- -- -- --
Income Tax Expense $4.5B $2.8B $890M $1.1B --
Net Income to Company $16.1B $11.2B $5.1B $3.9B --
 
Minority Interest in Earnings $1.5B $1.5B $1.6B $1.8B --
Net Income to Common Excl Extra Items $16B $11.2B $5.1B $5.9B --
 
Basic EPS (Cont. Ops) $28.79 $23.65 $9.97 $13.37 --
Diluted EPS (Cont. Ops) $28.60 $23.53 $9.94 $13.34 --
Weighted Average Basic Share $2.1B $1.6B $1.4B $1.2B --
Weighted Average Diluted Share $2.1B $1.6B $1.4B $1.2B --
 
EBITDA $23.5B $16.9B $9B $9.8B --
EBIT $20.3B $13.6B $5.7B $6.5B --
 
Revenue (Reported) $177.4B $148.5B $138.5B $132.5B --
Operating Income (Reported) $20.3B $13.6B $5.7B $6.5B --
Operating Income (Adjusted) $20.3B $13.6B $5.7B $6.5B --
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Cash and Equivalents $10.8B $11.8B $10.2B $3.2B $3.7B
Short Term Investments $5.5B $3.1B $4.8B -- --
Accounts Receivable, Net $11B $13.5B $11.6B $11.1B --
Inventory $8.1B $8.8B $9.3B $9.6B --
Prepaid Expenses -- -- -- -- --
Other Current Assets $568M $1.2B $403M $524M --
Total Current Assets $30.5B $35.2B $32.1B $24.4B --
 
Property Plant And Equipment $38.8B $36.9B $36.3B $36.3B --
Long-Term Investments $5.4B $6.5B $6.3B $6.9B --
Goodwill $8.3B $8.2B $8.2B $8.2B --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $2.4B $3.1B $3B $3B --
Total Assets $85.4B $89.9B $87.4B $80.4B --
 
Accounts Payable $13.7B $15.3B $13.8B $13.9B --
Accrued Expenses -- $315M $316M $314M --
Current Portion Of Long-Term Debt $571M $1.1B $2B $3B --
Current Portion Of Capital Lease Obligations $438M $368M $454M $417M --
Other Current Liabilities $1B $852M $1.3B $841M --
Total Current Liabilities $17.9B $20B $20.2B $20.8B --
 
Long-Term Debt $25.9B $26.5B $26.1B $25.3B $32.9B
Capital Leases -- -- -- -- --
Total Liabilities $51.8B $54.8B $56B $55.8B --
 
Common Stock $10M $10M $10M $10M --
Other Common Equity Adj -$67M $2M -$131M -$114M --
Common Equity $26.2B $27.7B $24.4B $17.7B $24.1B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $7.4B $7.4B $7B $6.8B --
Total Equity $33.6B $35.1B $31.4B $24.5B $24.1B
 
Total Liabilities and Equity $85.4B $89.9B $87.4B $80.4B $24.1B
Cash and Short Terms $10.8B $11.8B $10.2B $3.2B $3.7B
Total Debt $26.5B $27.5B $28B $28.3B $32.9B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Cash and Equivalents $10.8B $11.8B $10.2B $3.2B $3.7B
Short Term Investments $5.5B $3.1B $4.8B -- --
Accounts Receivable, Net $11B $13.5B $11.6B $11.1B --
Inventory $8.1B $8.8B $9.3B $9.6B --
Prepaid Expenses -- -- -- -- --
Other Current Assets $568M $1.2B $403M $524M --
Total Current Assets $30.5B $35.2B $32.1B $24.4B --
 
Property Plant And Equipment $38.8B $36.9B $36.3B $36.3B --
Long-Term Investments $5.4B $6.5B $6.3B $6.9B --
Goodwill $8.3B $8.2B $8.2B $8.2B --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $2.4B $3.1B $3B $3B --
Total Assets $85.4B $89.9B $87.4B $80.4B --
 
Accounts Payable $13.7B $15.3B $13.8B $13.9B --
Accrued Expenses -- $315M $316M $314M --
Current Portion Of Long-Term Debt $571M $1.1B $2B $3B --
Current Portion Of Capital Lease Obligations $438M $368M $454M $417M --
Other Current Liabilities $1B $852M $1.3B $841M --
Total Current Liabilities $17.9B $20B $20.2B $20.8B --
 
Long-Term Debt $25.9B $26.5B $26.1B $25.3B $32.9B
Capital Leases -- -- -- -- --
Total Liabilities $51.8B $54.8B $56B $55.8B --
 
Common Stock $10M $10M $10M $10M --
Other Common Equity Adj -$67M $2M -$131M -$114M --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $7.4B $7.4B $7B $6.8B --
Total Equity $33.6B $35.1B $31.4B $24.5B $24.1B
 
Total Liabilities and Equity $85.4B $89.9B $87.4B $80.4B $24.1B
Cash and Short Terms $10.8B $11.8B $10.2B $3.2B $3.7B
Total Debt $26.5B $27.5B $28B $28.3B $32.9B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $11B $16.1B $11.2B $5.1B --
Depreciation & Amoritzation $3.3B $3.2B $3.3B $3.3B --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$5.3B -$2.3B $2B $1.1B --
Change in Inventories -$33M -$787M -$489M -$270M --
Cash From Operations $4.4B $16.4B $14.1B $8.7B --
 
Capital Expenditures $1.5B $2.4B $1.9B $2.5B --
Cash Acquisitions $630M $904M $846M $1B --
Cash From Investing $14.2B $132M -$3.7B $1.2B --
 
Dividends Paid (Ex Special Dividend) $1.5B $1.3B $1.3B $1.2B --
Special Dividend Paid
Long-Term Debt Issued $19.6B $3.4B $1.6B $1.6B --
Long-Term Debt Repaid -$25.8B -$2.3B -$1.1B -$2B --
Repurchase of Common Stock $4.7B $11.9B $11.6B $9.2B --
Other Financing Activities -$2.1B -$1.8B -$1.9B -$1.8B --
Cash From Financing -$13.8B -$13.2B -$13.6B -$12.1B --
 
Beginning Cash (CF) $5.3B $8.6B $5.4B $3.2B $3.7B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $4.7B $3.3B -$3.2B -$2.2B --
Ending Cash (CF) $10B $12B $2.3B $975M --
 
Levered Free Cash Flow $2.9B $13.9B $12.2B $6.1B --
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $1.1B $3.6B $1.9B $785M --
Depreciation & Amoritzation $813M $797M $828M $826M --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$1.5B $56M $896M -$944M --
Change in Inventories $1.2B $1B $824M $318M --
Cash From Operations $3.7B $4.4B $1.1B $2.2B --
 
Capital Expenditures $481M $726M $532M $810M --
Cash Acquisitions $165M $515M $246M $166M --
Cash From Investing $1.3B -$674M -$964M $207M --
 
Dividends Paid (Ex Special Dividend) $354M $351M $311M $292M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.2B -- -- -- --
Long-Term Debt Repaid -$3.1B -$22M -$17M -$1.2B --
Repurchase of Common Stock $2.7B $1.8B $2.5B $1.4B --
Other Financing Activities -$691M -$485M -$338M -$474M --
Cash From Financing -$5.5B -$2.5B -$3.2B -$3.2B --
 
Beginning Cash (CF) $5.3B $8.6B $5.4B $3.2B $3.7B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$581M $1.2B -$3B -$793M --
Ending Cash (CF) $4.7B $9.9B $2.4B $2.4B --
 
Levered Free Cash Flow $3.2B $3.7B $591M $1.4B --
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $11B $16.1B $11.2B $5.1B --
Depreciation & Amoritzation $3.3B $3.2B $3.3B $3.3B --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$5.3B -$2.3B $2B $1.1B --
Change in Inventories -$33M -$787M -$489M -$270M --
Cash From Operations $4.4B $16.4B $14.1B $8.7B --
 
Capital Expenditures $1.5B $2.4B $1.9B $2.5B $2.3B
Cash Acquisitions $630M $904M $846M $1B --
Cash From Investing $14.2B $132M -$3.7B $1.2B --
 
Dividends Paid (Ex Special Dividend) $1.5B $1.3B $1.3B $1.2B --
Special Dividend Paid
Long-Term Debt Issued $19.6B $3.4B $1.6B $1.6B --
Long-Term Debt Repaid -$25.8B -$2.3B -$1.1B -$2B --
Repurchase of Common Stock $4.7B $11.9B $11.6B $9.2B --
Other Financing Activities -$2.1B -$1.8B -$1.9B -$1.8B --
Cash From Financing -$13.8B -$13.2B -$13.6B -$12.1B --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $4.7B $3.3B -$3.2B -$2.2B --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $2.9B $13.9B $12.2B $6.1B --
Period Ending 2022-12-31 2023-12-31 2024-12-31 2025-12-31 2026-12-31
Net Income to Stockholders $16.1B $11.2B $5.1B $3.9B --
Depreciation & Amoritzation $3.2B $3.3B $3.3B $2.4B --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$2.3B $2B $1.1B $706M --
Change in Inventories -$787M -$489M -$270M -$285M --
Cash From Operations $16.4B $14.1B $8.7B $5.2B --
 
Capital Expenditures $2.4B $1.9B $2.5B $2.3B --
Cash Acquisitions $904M $846M $1B $3.6B --
Cash From Investing $132M -$3.7B $1.2B -$6B --
 
Dividends Paid (Ex Special Dividend) $1.3B $1.3B $1.2B $840M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $3.4B $1.6B $1.6B $11B --
Long-Term Debt Repaid -$2.3B -$1.1B -$2B -$9.8B --
Repurchase of Common Stock $11.9B $11.6B $9.2B $2.5B --
Other Financing Activities -$1.8B -$1.9B -$1.8B -$1B --
Cash From Financing -$13.2B -$13.6B -$12.1B $212M --
 
Beginning Cash (CF) $22.4B $29.2B $14.8B $11.8B --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $3.3B -$3.2B -$2.2B -$557M --
Ending Cash (CF) $25.8B $26B $12.6B $7.6B --
 
Levered Free Cash Flow $13.9B $12.2B $6.1B $2.9B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 34x

Sell
44
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Buy
77
CPS alert for Feb 14

Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.

Buy
58
TPH alert for Feb 14

Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.

Sell
20
IRON alert for Feb 14

Disc Medicine, Inc. [IRON] is down 21.88% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock